{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:53Z","timestamp":1785575753221,"version":"3.56.0"},"reference-count":25,"publisher":"Japanese Pharmacological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1254\/jphs.08r32fm","type":"journal-article","created":{"date-parts":[[2009,7,22]],"date-time":"2009-07-22T05:59:04Z","timestamp":1248242344000},"page":"237-244","source":"Crossref","is-referenced-by-count":35,"title":["Analysis of the Mechanism for the Development of Allergic Skin Inflammation and the Application for Its Treatment: Aspirin Modulation of IgE-Dependent Mast Cell Activation: Role of Aspirin-Induced Exacerbation of Immediate Allergy"],"prefix":"10.1254","volume":"110","author":[{"given":"Yoshihiro","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisei","family":"Ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. 2003;28:123&ndash;127.","DOI":"10.1046\/j.1365-2230.2003.01228.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1592.2004.00319.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2007.03.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232&ndash;235.","DOI":"10.1038\/newbio231232a0"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-40668"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956&ndash;959.","DOI":"10.1126\/science.8052854"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1124\/mol.107.035212"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Mortaz E, Redegeld FA, Nijkamp FP, Engels F. Dual effects of acetylsalicylic acid on mast cell degranulation, expression of cyclooxygenase-2 and release of pro-inflammatory cytokines. Biochem Pharmacol. 2005;69:1049&ndash;1057.","DOI":"10.1016\/j.bcp.2004.12.018"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70167-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. Allergy. 2001;56:1061&ndash;1067.","DOI":"10.1111\/j.1398-9995.2001.00913.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01364.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, et al. Significant association of Fc&epsilon;RI&alpha; promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol. 2007;119:449&ndash;456.","DOI":"10.1016\/j.jaci.2006.10.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Togo K, Suzuki Y, Yoshimaru T, Inoue T, Terui T, Ochiai T, et al. Aspirin and salicylates modulate IgE-mediated leukotriene secretion in mast cells through a dihydropyridine receptor-mediated Ca<sup>2+<\/sup> influx. Clin Immunol. 2009;131:145&ndash;156.","DOI":"10.1016\/j.clim.2008.09.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol. 1996;98:751&ndash;758.","DOI":"10.1016\/S0091-6749(96)70123-9"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.27.16709"},{"issue":"3","key":"16","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0021-9258(18)53948-X","volume":"268","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009218200"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.8.4449"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M003395200"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Gij&oacute;n MA, Leslie CC. Regulation of arachidonic acid release and cytosolic phospholipase A<sub>2<\/sub> activation. J Leukoc Biol. 1999;65:330&ndash;336.","DOI":"10.1002\/jlb.65.3.330"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zweifach A, Lewis RS. Calcium-dependent potentiation of store-operated calcium channels in T lymphocytes. J Gen Physiol. 1996;107:597&ndash;610.","DOI":"10.1085\/jgp.107.5.597"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403969200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Chang WC, Nelson C, Parekh AB. Ca<sup>2+<\/sup> influx through CRAC channels activates cytosolic phospholipase A<sub>2<\/sub>, leukotriene C<sub>4<\/sub> secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells. FASEB J. 2006;20:2381&ndash;2383.","DOI":"10.1096\/fj.06-6016fje"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Suzuki Y, Yoshimaru T, Inoue T, Ra C. The high-affinity immunoglobulin E receptor (Fc&epsilon;RI) regulates mitochondrial calcium uptake and a dihydropyridine receptor-mediated calcium influx in mast cells: role of the Fc&epsilon;RI&beta; chain immunoreceptor tyrosine-based activation motif. Biochem Pharmacol. 2008;75:1492&ndash;1503.","DOI":"10.1016\/j.bcp.2007.12.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yoshimaru T, Suzuki Y, Inoue T, Ra C. L-type Ca<sup>2+<\/sup> channels in mast cells: activation by membrane depolarization and distinct roles in regulating mediator release from store-operated Ca<sup>2+<\/sup> channels. Mol Immunol. 2009;46:1267&ndash;1277.","DOI":"10.1016\/j.molimm.2008.11.011"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T23:18:02Z","timestamp":1633735082000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/110\/3\/110_08R32FM\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.08r32fm","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}